Antibacterial activity and drug release of chitosan sponge containing doxycycline hyclate

AAPS PharmSciTech

Volumn 9, Issue 3, 2008, Pages 829-835

  Phaechamud, Thawatchai ^a   Charoenteeraboon, Juree ^a  

^a SILPAKORN UNIVERSITY   (Thailand)

Author keywords

Antibacterial activity; Chitosan sponge; Doxycycline hyclate; Drug release

Indexed keywords

BUFFER; CHITOSAN; DOXYCYCLINE HYCLATE; GLUTARALDEHYDE; PHOSPHATE;

AGAR DIFFUSION; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATION; CONTROLLED STUDY; CROSS LINKING; DRUG DIFFUSION; DRUG RELEASE; DRUG SOLUBILITY; ESCHERICHIA COLI; FREEZE DRYING; NONHUMAN; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; CHITOSAN; DELAYED-ACTION PREPARATIONS; DOXYCYCLINE; DRUG CARRIERS; ESCHERICHIA COLI; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCUS AUREUS; SURGICAL SPONGES;

EID: 57149124247     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-008-9117-x     Document Type: Article

References (17)

1. O. Felt, P. Buri, and R. Gurny. Chitosan: A unique polysaccharide for drug delivery. Drug Dev. Ind. Pharm. 24 (11):979-993 (1998).
2. J. Berger, M. Reist, J. M. Mayer, O. Felt, N. A. Peppas, and R. Gurny. Structure and interactions in covalently and ionically cross-linked chitosan hydrogels for biomedical applications. Eur. J. Pharm. Biopharm. 57: 19-34 (2004).
3. H. Ikeda, K. Takayama, and T. Nagai. Drug permeation behavior in chitosan film prepared on the metal plate laded with enteric charge. Chem. Pharm. Bull. 45 (1):221-223 (1997).
4. Y. Kato, H. Onishi, and Y. Machida. Application of chitin and chitosan derivatives in the pharmaceutical field. Curr. Pharm. Biotechnol. 4 (5):303-309 (2003).
5. F. L. Mi, Y. B. Wu, S. S. Shyu, J. Y. Schoung, Y. B. Huang et al. Control of wound infections using a bilayer chitosan wound dressing with sustainable antibiotic delivery. J. Biomed. Mater. Res. 59 (3):438-449 (2002).
6. Y. Zhang, and M. Zhang. Calcium phosphate/chitosan composite scaffolds for controlled in vitro antibiotic drug release. J. Biomed. Mater. Res. 62 (3):378-386 (2002).
7. F. L. Mi, S. S. Shyu, Y. B. Wu, S. T. Lee, J. Y. Shyong, and R. N. Huang. Fabrication and characterization of a sponge-like asymmetric chitosan membrane as a wound dressing. Biomaterials. 22 (2):165-173 (2001).
8. Y. J. Park, Y. M. Lee, J. Y. Lee, Y. J. Seol, C. P. Chung, and S. J. Lee. Controlled release of platelet-derived growth factor-BB from chondroitin sulfate-chitosan sponge for guided bone regeneration. J. Control. Release. 67 (2-3):385-394 (2000).
9. C. W. Stratton, and V. Lorian. Mechanisms of action for antimicrobial agents: General principals and mechanisms for selected classes of antibiotics, antibiotics in laboratory medicine, 4th ed., Williams & Wilkins, Baltimore, 1996.
10. J. J. Reynolds, and M. C. Meikle. Mechanisms of connective tissue matrix destruction in periodontitis. Periodontology. 2000: 144-157 (1997).
11. C. Ohrt, T. L. Richie, H. Widjaja, G. D. Shanks, J. Fitriadi et al. Mefloquine compared with doxycycline for the prophylaxis of malaria in Indonesian soldiers. A randomized, double-blind, placebo-controlled trial. Ann. Int. Med. 126 (12):963-972 (1997).
12. MicroMath Scientist Handbook Rev. 7EEF, MicroMath: Salt Lake City, 1995, p. 467.
13. N. H. Foda, H. M. El-laithy, and M. I. Tadros. Optimization of biodegradable sponges as controlled release drug matrices. I. Effect of moisture level on chitosan sponge mechanical properties. Drug Ind. Dev. Pharm. 30 (4):369-379 (2004).
14. K. Oungbho, and B. W. Muller. Chitosan sponges as sustained release drug carriers. Inter. J. Pharm. 156: 229-237 (1997).
15. P. L. Ritger, and N. A. Peppas. A simple equation for description of solute release. II. Fickian and anomalous release from swellable devices. J. Control. Release. 5: 37-342 (1987).
16. N. A. Peppas. Analysis of Fickian and non-Fickian drug release from polymers. Pharm. Acta. Helv. 60 (4):110-111 (1985).
17. J. Nerurkar, H. W. Jun, J. C. Price, and M. O. Park. Controlled-release matrix tablets of ibuprofen using cellulose ethers and carrageenans: effect of formulation factors on dissolution rates. Eur. J. Pharm. Biopharm. 61: 56-68 (2005).